Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_assertion type Assertion NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_head.
- NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_assertion description "[The ability of PDE5 inhibitors to increase RV inotropy and to decrease RV afterload without significantly affecting systemic hemodynamics makes them ideal for the treatment of diseases affecting the RV, including pulmonary arterial hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_provenance.
- NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_assertion evidence source_evidence_literature NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_provenance.
- NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_assertion SIO_000772 17606845 NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_provenance.
- NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_assertion wasDerivedFrom befree-2016 NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_provenance.
- NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_assertion wasGeneratedBy ECO_0000203 NP618193.RATZMuEQZkxdccLzOk_4bByJV6aipJqZwCAnxS2qQJ-Kw130_provenance.